Takeda Pharmaceutical has been supporting the Global Fund since 2010, making it the longest corporate partnership to date in contributing to the fight against communicable diseases. Based on its commitment to “Better Health and a Brighter Future,” the company launched the “Takeda Initiative” in a ten-year commitment to contribute approximately US1$ million per year to help strengthen the capacity of health workers in Africa.
It then renewed this partnership for a further five years in 2019 as the first private sector pledge at the Sixth Replenishment. Called the “Takeda Initiative 2,” this next phase of partnership supports the improvement of maternal and child health by integrating quality HIV, tuberculosis, and malaria services in antenatal and postnatal care in Africa. FGFJ helped make the original connection between Takeda Pharmaceutical and the Global Fund, and has continued to facilitate communication between the two for a successful continuation of the partnership. FGFJ also tries to leverage the unprecedented Japanese corporate contribution to encourage other companies in Japan to contribute to the work of the Global Fund as well.
[2020–2024: Improvement of maternal and child health by integrating quality HIV, TB, and malaria services in antenatal and postnatal care in several priority countries in Africa]
[2010–2019: Health system strengthening and human capacity development initiatives in Africa]
Global Fund press announcement for 2020–2024 commitment: English / JapaneseTakeda Pharmaceutical Company announcement
Global Fund press announcement for 2010–2019 commitment: English / Japanese
Meisan Tameike Bldg. 7F, 1-1-12 Akasaka, Minato-ku, Tokyo, Japan 107-0052
Phone: 81-3-6277-7811FAX : 03-6277-6712Email: fgfj @ jcie.or.jp
© Japan Center for International ExchangeAll Rights Reserved.
Privacy | Sitemap